Harrow Health Inc
NASDAQ:HROW
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Harrow Health Inc
NASDAQ:HROW
|
US |
|
T
|
Thinkific Labs Inc
TSX:THNC
|
CA |
|
L
|
Lippo China Resources Ltd
HKEX:156
|
HK |
|
I
|
Insecticides (India) Ltd
NSE:INSECTICID
|
IN |
|
CIELO SA Instituicao de Pagamento
F:28MA
|
BR |
|
G
|
Grupo Ecoener SA
MAD:ENER
|
ES |
|
Mineral Resources Ltd
ASX:MIN
|
AU |
Wall Street
Price Targets
HROW Price Targets Summary
Harrow Health Inc
According to Wall Street analysts, the average 1-year price target for
HROW
is 69.36 USD
with a low forecast of 59.59 USD and a high forecast of 95.55 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is HROW's stock price target?
Price Target
69.36
USD
According to Wall Street analysts, the average 1-year price target for
HROW
is 69.36 USD
with a low forecast of 59.59 USD and a high forecast of 95.55 USD.
What is Harrow Health Inc's Revenue forecast?
Projected CAGR
39%
The
compound annual growth rate
of Harrow Health Inc's revenue for the next 3 years is
39%.
What is Harrow Health Inc's Operating Income forecast?
Projected CAGR
104%
The
compound annual growth rate
of Harrow Health Inc's operating income for the next 3 years is
104%.
